Introduction
Type 2 diabetes (T2D) is a chronic metabolic disease characterized by an elevated level of blood glucose. Microvascular and macrovascular complications of T2D such as retinopathy, nephropathy, neuropathy—which may lead to blindness, renal failure and amputation—and cardiovascular diseases (CVD) exert a high financial burden for people with diabetes and for the health system. The progression of T2D is slow and may last several years before diagnosis. In the early stage of T2D, people with T2D may not show any symptoms and therefore not be detected and not get treated, whereas microvascular and macrovascular complications may have already developed during this stage.1 2 It is estimated that 13% of adults with T2D have diabetic retinopathy at the time of diagnosis and many of them have CVD.3 4 Undiagnosed T2D bears a high risk for long-term microvascular and macrovascular complications and for a higher mortality compared with normoglycemic individuals.5 6 Identification of undiagnosed T2D at an early stage is thus of importance for a timely care.
While general screening for undiagnosed T2D among asymptomatic individuals may well reduce CVD and mortality risk among those who are detected by screening,7 8 benefits at the population level regarding a reduction in mortality or cardiovascular event rates are less clear.9 Case finding strategies or opportunistic screening within the healthcare settings has been proposed to be more efficient.10 As these strategies will not reach individuals at high risk who do not regularly use healthcare services, risk communication to the public is also a crucial part of a national diabetes strategy. Identifying characteristics related to undiagnosed diabetes would be valuable to both, case finding and risk communication strategies.
Undiagnosed diabetes remains a problem even in high-income countries with universal access to healthcare.11 12 In Germany, 2% of the adult population 18–79 years of age were estimated to have undiagnosed diabetes based on laboratory testing for glycated hemoglobin A1c (HbA1c) as part of the German Health Interview and Examination Survey 2008–2011 (DEGS1).13 Undiagnosed diabetes accounted for about 22% of total diabetes.13 In stratified analyses, both diagnosed as well as undiagnosed diabetes were more prevalent among men than women, older adults, those with obesity and those with low education.13 However, correlates specific to undiagnosed diabetes in Germany have not been systematically investigated so far. Correlates and predictors of undiagnosed diabetes have been previously investigated in several other high-income countries such as the USA,14–16 the UK,17 18 Denmark,19 Ireland,20 21 South Korea22 as well as in some low-income countries.23–27 Results of previous studies from high-income countries vary, which may be explained, at least in part, by differences in study design, characteristics of the study population as well as health system factors.14–22 There is evidence, however, from some studies that personal context factors, such as healthcare utilization behavior and marital or cohabitation status are factors associated with undiagnosed diabetes.28
Against this background, the present study aimed to identify clinical, sociodemographic and behavioral characteristics of adults with undiagnosed diabetes in Germany. We specifically sought to identify factors correlated with undiagnosed but not diagnosed diabetes.